Trade

Par Drugs and Chemicals share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • ₹89.59(-0.78%)
    March 12, 2026 15:29:07 PM IST
    • NSE
    • BSE
  • Vol : 8.88 K (NSE + BSE)
    Last 20 day avg : 10.17 K

Par Drugs and Chemicals is trading -0.78% lower at Rs 89.59 as compared to its last closing price. Par Drugs and Chemicals has been trading in the price range of 91.10 & 88.00. Par Drugs and Chemicals has given -10.83% in this year & -0.31% in the last 5 days. Par Drugs and Chemicals has TTM P/E ratio 8.96 as compared to the sector P/E of 23.45.The company posted a net profit of 4.80 Crores in its last quarter.Listed peers of Par Drugs and Chemicals include Dr Reddy's Laboratories (-0.41%), Sun Pharmaceutical Industries (0.01%), Cipla (-0.35%).The Mutual Fund holding in Par Drugs and Chemicals was at -% in . The MF holding has - from the last quarter. The FII holding in Par Drugs and Chemicals was at 0.09% in 30 Sep 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Mar 12, 2026, 01:47 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.03
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.62
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
88.00
Highest
91.10
52 week range
Lowest
81.01
Highest
122.43
Par Drugs and Chemicals News
Par Drugs and Chemicals Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bullish
1,320.00-0.411,10,167.7318.633.140.632.34
Sun Pharmaceutical Industries
Bullish
1,825.000.014,37,868.3136.245.770.920.50
Cipla
Bearish
1,325.25-0.351,06,962.6622.953.870.870.81
Divi's Laboratories
Bearish
6,289.95-0.931,67,430.6678.6111.520.460.01
Torrent Pharmaceuticals
Bullish
4,439.500.231,50,559.5467.3217.10.8317.62
Par Drugs and Chemicals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-10Quarterly Results & Others
2025-11-13Quarterly Results & Others
2025-08-29Others
2025-08-07Quarterly Results & Others
2025-05-08Audited Results & Others
About the company Par Drugs and Chemicals
  • IndustryBiotechnology & Drugs
  • ISININE04LG01015
  • BSE Code
  • NSE CodePAR
Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.
  • Management Info
  • Falgun SavaniChairman of the Board, Managing Director, Promoter
  • Jignesh SavaniChief Executive Officer, Executive Director, Promoter
  • Chintan ChauhanChief Financial Officer
  • Sanket TrivediCompliance Officer, Company Secretary
  • Ghanshayambhai SavaniWhole Time Director
Par Drugs and Chemicals Share Price FAQs

Par Drugs and Chemicals is trading at 89.59 as on Thu Mar 12 2026 09:59:07. This is -0.78% lower as compared to its previous closing price of 90.29.

The market capitalization of Par Drugs and Chemicals is 110.24 Cr as on Thu Mar 12 2026 09:59:07.

The 52 wk high for Par Drugs and Chemicals is 122.43 whereas the 52 wk low is 81.01

Par Drugs and Chemicals can be analyzed on the following key metrics -

  • TTM P/E: 8.96
  • Sector P/E: 23.45
  • Dividend Yield: 0.00%
  • D/E ratio: -

Par Drugs and Chemicals reported a net profit of 13.36 Cr in 2025.

Quick Links
EQUITY QUICK LINKS
Par Drugs and Chemicals QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Par Drugs and Chemicals share price